Development of pharmaceutically relevant bio-based intermediates though aldol condensation and Claisen–Schmidt reactions of dihydrolevoglucosenone (Cyrene®)
Dihydrolevoglucosenone (Cyrene®) has been successfully utilised as a bio-based platform molecule for the synthesis of pharmaceutically relevant intermediates through aldol condensation reactions.
1997 ◽
Vol 38
(25)
◽
pp. 4473-4476
◽
2015 ◽
2000 ◽
Vol 41
(21)
◽
pp. 4213-4217
◽
Keyword(s):